Detalles de la búsqueda
1.
High-dose chemotherapy and peripheral blood stem cell transplantation as salvage therapy in primary mediastinal nonseminomatous germ cell tumors: The Indiana University experience.
Cancer
; 2024 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38768296
2.
Surveillance after Complete Response to First-Line Chemotherapy in Patients with Metastatic Nonseminomatous Germ Cell Tumor.
J Urol
; 208(3): 641-649, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35674780
3.
A phase II study assessing the safety and efficacy of ASP1650 in male patients with relapsed refractory germ cell tumors.
Invest New Drugs
; 40(5): 1087-1094, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35759134
4.
Relations of perceived injustice to psycho-spiritual outcomes in advanced lung and prostate cancer: Examining the role of acceptance and meaning making.
Psychooncology
; 31(12): 2177-2184, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36336876
5.
Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments.
Ear Hear
; 43(3): 794-807, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35067571
6.
Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high-dose chemotherapy and peripheral blood stem cell transplantation.
Cancer
; 127(20): 3751-3760, 2021 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34260067
7.
Pearls and perils in the management of germ cell tumors.
Curr Opin Oncol
; 33(3): 206-211, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33577208
8.
Percentage of Teratoma in Orchiectomy and Risk of Retroperitoneal Teratoma at the Time of Postchemotherapy Retroperitoneal Lymph Node Dissection in Germ Cell Tumors.
J Urol
; 206(6): 1430-1437, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34288715
9.
Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors.
Invest New Drugs
; 39(6): 1656-1663, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34031784
10.
Measurement of patients' acceptable symptom levels and priorities for symptom improvement in advanced lung cancer.
Support Care Cancer
; 29(10): 5895-5904, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33763726
11.
Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724).
Support Care Cancer
; 29(2): 833-840, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32500206
12.
High-dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases.
Cancer
; 126(6): 1202-1207, 2020 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31743434
13.
Management of residual disease after chemotherapy in germ cell tumors.
Curr Opin Oncol
; 32(3): 250-255, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32168037
14.
Long-Term Oncologic Outcomes after Primary Retroperitoneal Lymph Node Dissection: Minimizing the Need for Adjuvant Chemotherapy.
J Urol
; 204(1): 96-103, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32003612
15.
The effects of hypogonadism on quality of life in survivors of germ cell tumors treated with surgery alone versus surgery plus platinum-based chemotherapy.
Support Care Cancer
; 28(7): 3165-3170, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31707501
16.
A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors.
Invest New Drugs
; 37(4): 738-747, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30993587
17.
Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors.
J Natl Compr Canc Netw
; 17(5): 459-468, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31085753
18.
Treatment of CD30-Expressing Germ Cell Tumors and Sex Cord Stromal Tumors with Brentuximab Vedotin: Identification and Report of Seven Cases.
Oncologist
; 23(3): 316-323, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29222199
19.
Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors.
J Natl Compr Canc Netw
; 16(3): 257-265, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29523664
20.
2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting.
Support Care Cancer
; 25(1): 303-308, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27815710